H.Res. 93 House Congress
Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
STAGE 4 OF 8 — HOUSE FLOOR
Currently in the House. Last action: motion to reconsider laid on the table agreed to without objection on Feb 5, 2025.
- House Submitted in House Feb 4, 2025
- House Reported in House Feb 4, 2025
- House The House Committee on Rules reported an original measure, H. Rept. 119-2, by Mr. Griffith. Feb 4, 2025
- House The resolution makes in order only the further amendment printed in Part B of the Rules Committee report. Feb 4, 2025
- House Placed on the House Calendar, Calendar No. 2. Feb 4, 2025
- House Considered as privileged matter. (consideration: CR H469-478) Feb 5, 2025
- House DEBATE - The House proceeded with one hour of debate on H. Res. 93. Feb 5, 2025
- House POSTPONED PROCEEDINGS - At the conclusion of debate on H. Res. 93, the Chair put the question on ordering the previous question and by voice vote announced that the ayes had prevailed. Mr. McGovern demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced. Feb 5, 2025
- House Considered as unfinished business. (consideration: CR H482-483) Feb 5, 2025
- House On ordering the previous question Agreed to by the Yeas and Nays: 212 - 208 (Roll no. 30). (consideration: CR H482) Feb 5, 2025
- House Passed/agreed to in House: On agreeing to the resolution Agreed to by recorded vote: 215 - 208 (Roll no. 31). (text: CR H469) Feb 5, 2025
- House On agreeing to the resolution Agreed to by recorded vote: 215 - 208 (Roll no. 31). (text: CR H469) Feb 5, 2025
- House Motion to reconsider laid on the table Agreed to without objection. Feb 5, 2025
- HouseOn Ordering the Previous Question Feb 5, 2025
- House Latest voteOn Agreeing to the Resolution Feb 5, 2025
Subjects
House of RepresentativesLegislative rules and procedure
Committees
- Rules Committee
- Reported Original Measure , Feb 4, 2025
Summary
No summary available.
Comments · 0
Please log in to post a comment.
Loading comments...